SEMAGLUTIDE | Reference Standard

Incretin Signaling, Glucose Homeostasis & Appetite Regulation Research

Category:
Metabolic Signaling • Incretin Biology • Glucose Regulation • Energy Balance Research

 

What Researchers Study

Semaglutide is a long-acting synthetic glucagon-like peptide-1 (GLP-1) receptor agonist engineered to resist enzymatic degradation and exhibit prolonged systemic activity via albumin binding.

Researchers study Semaglutide because it enables:

• Precise investigation of GLP-1 receptor biology

• Long-duration incretin signaling models

• Appetite and satiety pathway mapping

• Glucose regulation independent of insulin analogs

Its extended half-life makes it especially valuable for chronic metabolic and longitudinal studies.

 

Primary Signal Pathways Studied

• GLP-1 receptor (GLP-1R) activation

• Central appetite and satiety signaling

• Pancreatic β-cell insulin secretion

• Glucagon suppression

• Gastric emptying modulation

• Brain–gut axis integration

 

Why This Molecule Is Studied

Semaglutide is studied as a reference-grade GLP-1 agonist because it offers:

• High receptor specificity

• Predictable pharmacokinetics

• Sustained signaling without continuous dosing

• Clear separation of incretin effects vs caloric restriction

It is frequently used as a benchmark compound when evaluating newer dual- or triple-agonist peptides.

 

Mechanistic Overview

Semaglutide binds the GLP-1 receptor, a class B G-protein–coupled receptor expressed in:

• Pancreatic islets

• Hypothalamic appetite centers

• Gastrointestinal tract

Activation leads to:

• Glucose-dependent insulin secretion

• Suppression of glucagon release

• Delayed gastric emptying

• Central satiety signaling

Structural modifications (fatty-acid acylation) enable albumin binding, dramatically extending circulation time and signaling duration.

 

Key Research Domains

1. Glucose Homeostasis & Insulin Sensitivity

Used to study:

• Post-prandial glucose handling

• β-cell functional capacity

• Glucose-dependent insulin secretion

Common endpoints include fasting glucose, insulin curves, and clamp studies.

2. Appetite & Energy Intake Regulation

Semaglutide is widely used in:

• Feeding behavior models

• Hypothalamic signaling studies

• Brainstem appetite circuit mapping

Allows isolation of central satiety signaling without stimulant or aversive pathways.

3. Weight & Adiposity Research

Frequently applied in:

• Obesity and diet-induced weight gain models

• Visceral vs subcutaneous fat analysis

• Lean mass preservation studies

Often paired with DEXA, MRI, or histological analysis.

4. Comparative Incretin Biology

Semaglutide serves as a control or comparator for:

• Dual agonists (GLP-1/GIP)

• Triple agonists (GLP-1/GIP/Glucagon)

• Short-acting GLP-1 analogs

 

Research Context Considerations

• Effects are dose- and duration-dependent

• Chronic exposure yields different outcomes than acute dosing

• Central vs peripheral signaling contributions vary by model

• Species-specific GLP-1 receptor distribution should be considered

 

Product Specifications

• Compound Name: Semaglutide

• CAS Number: 910463-68-2

• Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉

• Molecular Weight: 4,113.64 Da

• Peptide Class: Long-acting GLP-1 receptor agonist

• Purity: ≥98% (HPLC verified)

• Form: Lyophilized powder

• Appearance: White to off-white solid

• Storage: ≤ –20 °C, desiccated, protected from light

 

Batch Documentation & Traceability

Each vial is shipped with a lot-specific QR code that provides secure access to batch documentation, including:

• Certificate of Analysis (COA)
• Identity verification report (HPLC / MS)
• Lot number, potency, and expiration

Documentation is locked to the specific batch shipped to ensure traceability, version control, and research reproducibility.

QR access is provided with the physical product and is not reused across lots.

 

Research Use Disclaimer

This compound is supplied exclusively for laboratory research use.
Not for human or veterinary use.
Not for diagnostic, therapeutic, or consumptive applications.